PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks
At ASH 2015, Dr. Srdan Verstovsek from MD Anderson Cancer Center discussed his abstract titled "PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks."
Recent Video
Most Popular
Specialties :                    Search :


MPNUniversity.tv is a member of the Oncology.TV family of oncology medical education websites. MPNUniversity.tv offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).